You might want to look at ANX and INO. They are both at about 0.80 and look like they are just now starting to run up to over a $1 as DARA did. ANX just initiated a phase III trial and INO has several potential catalysts this year.
TEAR looks great. It is in the $5 range but they have a monopoly on "Dry Eye" testing procedure. They get reimbursement from CMS at $42 plus a pop. They are literally printing money. Have gone from 1s to 5s in less than 12 months and revenues are still increasing.